Fundraising FoxHighbury Holdings — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Shape Therapeuticsshapetx.comin𝕏Series A · Nov 2019 · $36M
ShapeTX develops programmable RNA medicines by combining artificial intelligence with RNA technology to address genetic causes of disease.
AI & Machine LearningBiotechDeep Tech
Josef von Rickenbach, PhD(Co-Founder)in
Co-investorsNew Enterprise Associates (NEA)Decheng CapitalMission Biocapital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.